Trending Now
Argentina Makes An Official Announcement Of The COVID-19 Vaccine Supply Deal...
Moderna Inc (NASDAQ: MRNA) is back in the news. This time it regards a vaccine procurement deal. Recently, Argentina makes an official announcement of...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Anavex Life Sciences Corp (NASDAQ:AVXL) Commences Phase 1 Clinical Study Of...
Anavex Life Sciences Corp (NASDAQ:AVXL) began phase 1 clinical study of innovative formulation ANAVEX3-71 by enrolling the first patient. The small molecule, which is...
MAKE IT MODERN
LATEST REVIEWS
Capitalizing on the Generational Washout in Crypto Markets (RIOT, BLQC, COIN,...
After the past week, the cryptocurrency space is now the poster child for this bear market in global risk assets. It has...
MAKE IT MODERN
PERFORMANCE TRAINING
Luxury Goods Retailers Take Flight (SIG, LVMUY, SKDI, TPR)
With the economy rapidly approaching a period of normalization spurred by vaccine-induced herd immunity, high-end retailers are embracing a new dawn, helped...
Vericel Corp (NASDAQ:VCEL) Expect To Record Net Revenues Of $20 Million In Q2 2020
Vericel Corp (NASDAQ:VCEL) expects to report a drop of 23% in Q2 2020 revenues to $20 million. Net revenues of MACI and Epicel, the...
Canadian Biotech Disruptor Lexston Life Sciences is unlocking the God Molecule (LEXTF, ICPT, AKBA,...
Investors were all spooked today with Dow plummeting more than 500 points. The primary cause can be attributed to inflation fears, disappointing...
Incyte Corporation (NASDAQ: INCY) Receives Approval For Opzelura In Atopic Dermatitis
Incyte Corporation (NASDAQ: INCY) has announced the US FDA has approved Opzelura cream for non-continuous and short-term chronic treatment for atopic dermatitis in non-immunocompromised...
Genelux Corporation (GNLX) Stock Plummets After Pricing Public Offering
Genelux Corporation (NASDAQ: GNLX), a biopharmaceutical company dedicated to developing oncolytic immunotherapies, recently faced a dramatic decline in its stock price. Following...
MAKE IT MODERN
